Tom Sheeran

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Maxime Dougados, K. Kissel, Tom Sheeran et al. · Annals of the Rheumatic Diseases · 2012 · 287 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Ariane L. Herrick, Xiaoyan Pan, Sébastien Peytrignet et al. · Annals of the Rheumatic Diseases · 2017 · 139 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double‐blind, placebo‐controlled trial of the angiotensin‐converting enzyme inhibitor quinapril

A. Gliddon, Caroline J Doré, C. M. Black et al. · Arthritis & Rheumatism · 2007 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +13

RELIABILITY OF SKIN INVOLVEMENT MEASURES IN SCLERODERMA

Paul Brennan, Alan J. Silman, C Black et al. · Lara D. Veeken · 1992 · 111 citations

Medicine, Dermatology, Dermatopathology +12

VALIDITY AND RELIABILITY OF THREE METHODS USED IN THE DIAGNOSIS OF RAYNAUD'S PHENOMENON

Paul Brennan, Alan J. Silman, C Black et al. · Lara D. Veeken · 1993 · 92 citations

Medicine, Radiology, Clinical Classification Systems +8